Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model

Intensive Care Medicine Experimental

Volumn 1, Issue 1, 2013, Pages

  Struck, Joachim ^a   Hein, Frauke ^a   Karasch, Siegmund ^b   Bergmann, Andreas ^a  

^a ADRENOMED AG   (Germany)

^b ICI GmbH   (Germany)

Author keywords

Adrenomedullin; Animal model; Monoclonal antibodies; Sepsis; Therapy

Indexed keywords

EID: 84975111269     PISSN: None     EISSN: 2197425X     Source Type: Journal    
DOI: 10.1186/2197-425X-1-3     Document Type: Article

References (32)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001,29(7):1303–1310. 10.1097/00003246-200107000-00002 DOI: 10.1097/00003246-200107000-00002
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003,348(16):1546–1554. 10.1056/NEJMoa022139 DOI: 10.1056/NEJMoa022139
3. Melamed A, Sorvillo FJ: The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data. Crit Care 2009,13(1):R28. 10.1186/cc7733 DOI: 10.1186/cc7733
4. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P: Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 2012,93(3):329–42. DOI: 10.1189/jlb.0912437
5. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003,348(2):138–150. 10.1056/NEJMra021333 DOI: 10.1056/NEJMra021333
6. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 2003,9(5):517–524. 10.1038/nm0503-517 DOI: 10.1038/nm0503-517
7. Vincent JL: The rise and fall of drotrecogin alfa (activated). Lancet Infect Dis 2012,12(9):649–651. 10.1016/S1473-3099(12)70175-5 DOI: 10.1016/S1473-3099(12)70175-5
8. Sprung CL, Annane D, Singer M, Moreno R, Keh D, Group CS: Glucocorticoids in sepsis: dissecting facts from fiction. Crit Care 2011,15(5):446. 10.1186/cc10428 DOI: 10.1186/cc10428
9. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008,358(2):125–139. 10.1056/NEJMoa070716 DOI: 10.1056/NEJMoa070716
10. Abraham E: Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 1999,25(6):556–566. 10.1007/s001340050903 DOI: 10.1007/s001340050903
11. Wang P, Ba ZF, Cioffi WG, Bland KI, Chaudry IH: The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis. Arch Surg 1998,133(12):1298–1304. 10.1001/archsurg.133.12.1298 DOI: 10.1001/archsurg.133.12.1298
12. Yang S, Zhou M, Chaudry IH, Wang P: Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann Surg 2002,236(5):625–633. 10.1097/00000658-200211000-00013 DOI: 10.1097/00000658-200211000-00013
13. Zhou M, Ba ZF, Chaudry IH, Wang P: Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis. Am J Physiol Regul Integr Comp Physiol 2002,283(3):R553–560. DOI: 10.1152/ajpregu.00544.2001
14. Fowler DE, Yang S, Zhou M, Chaudry IH, Simms HH, Wang P: Adrenomedullin and adrenomedullin binding protein-1: their role in the septic response. J Surg Res 2003,109(2):175–181. 10.1016/S0022-4804(02)00086-0 DOI: 10.1016/S0022-4804(02)00086-0
15. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993,192(2):553–560. 10.1006/bbrc.1993.1451 DOI: 10.1006/bbrc.1993.1451
16. Hinson JP, Kapas S, Smith DM: Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000,21(2):138–167. 10.1210/er.21.2.138
17. Beltowski J, Jamroz A: Adrenomedullin–what do we know 10 years since its discovery? Pol J Pharmacol 2004,56(1):5–27.
18. Temmesfeld-Wollbruck B, Brell B, David I, Dorenberg M, Adolphs J, Schmeck B, Suttorp N, Hippenstiel S: Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock. Intensive Care Med 2007,33(4):703–710. 10.1007/s00134-007-0561-y DOI: 10.1007/s00134-007-0561-y
19. Gonzalez-Rey E, Chorny A, Varela N, Robledo G, Delgado M: Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am J Pathol 2006,168(6):1921–1930. 10.2353/ajpath.2006.051104 DOI: 10.2353/ajpath.2006.051104
20. Zhou M, Maitra SR, Wang P: Adrenomedullin and adrenomedullin binding protein-1 protect endothelium-dependent vascular relaxation in sepsis. Mol Med 2007,13(9–10):488–494.
21. Wu R, Higuchi S, Dong W, Ji Y, Zhou M, Marini CP, Ravikumar TS, Wang P: Reversing established sepsis in rats with human vasoactive hormone adrenomedullin and its binding protein. Mol Med 2009,15(1–2):28–33.
22. Hyvelin JM, Shan Q, Bourreau JP: Adrenomedullin: a cardiac depressant factor in septic shock. J Card Surg 2002,17(4):328–335. DOI: 10.1111/j.1540-8191.2001.tb01152.x
23. Karpinich NO, Hoopes SL, Kechele DO, Lenhart PM, Caron KM: Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models. Curr Hypertens Rev 2011,7(4):228–239. 10.2174/157340211799304761 DOI: 10.2174/157340211799304761
24. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F: Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996,81(4):1449–1453. 10.1210/jc.81.4.1449
25. Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE: High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association 1997,105(3):156–162. 10.1055/s-0029-1211745 DOI: 10.1055/s-0029-1211745
26. Ueda S, Nishio K, Minamino N, Kubo A, Akai Y, Kangawa K, Matsuo H, Fujimura Y, Yoshioka A, Masui K, Doi N, Murao Y, Miyamoto S: Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 1999,160(1):132–136. 10.1164/ajrccm.160.1.9810006 DOI: 10.1164/ajrccm.160.1.9810006
27. Westphal M, Sander J, Van Aken H, Ertmer C, Stubbe HD, Booke M: [Role of adrenomedullin in the pathogenesis and treatment of cardiovascular dysfunctions and sepsis]. Anaesthesist 2006,55(2):171–178. 10.1007/s00101-005-0888-0 DOI: 10.1007/s00101-005-0888-0
28. Colman RW: The role of plasma proteases in septic shock. N Engl J Med 1989,320(18):1207–1209. 10.1056/NEJM198905043201809 DOI: 10.1056/NEJM198905043201809
29. Mittra S, Hyvelin JM, Shan Q, Tang F, Bourreau JP: Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis? Am J Physiol Heart Circ Physiol 2004,286(3):H1034–1042. DOI: 10.1152/ajpheart.00337.2003
30. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR: Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997,82(1):95–100. 10.1210/jc.82.1.95
31. Lewis LK, Smith MW, Brennan SO, Yandle TG, Richards AM, Nicholls MG: Degradation of human adrenomedullin(1–52) by plasma membrane enzymes and identification of metabolites. Peptides 1997,18(5):733–739. 10.1016/S0196-9781(97)00005-3 DOI: 10.1016/S0196-9781(97)00005-3
32. Lewis LK, Smith MW, Yandle TG, Richards AM, Nicholls MG: Adrenomedullin(1–52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem 1998,44(3):571–577.